“The NHS has updated its guidelines for prescribing Mounjaro (tirzepatide) for weight management, effective from June 23, 2025. Adults are eligible if they have a BMI of 40 or more, or 37.5 or more for individuals from Black, Asian, and Minority Ethnic (BAME) backgrounds, and have four or more...